A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa

NCT05926583 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

GENETIC: AAV5-hRKp.RPGR
GENETIC: AAV5-hRKp.RPGR

Sponsor

Janssen Pharmaceutical K.K.